Clinical
Trials Research and Billing First in Human / Early Phase PET in Oncology Case - Based Dose Reduction in Pediatric Nuclear Medicine: Practical and Necessary Radioiodine
Therapy for Hyperthyroidism: The State
of the Art Spondylodiscitis: Role
of Imaging for Diagnosis and Monitoring Treatment Response Current Status and Future Prospects: PET and SPECT Instrumentation
Alternative Payment Models and Value - Based Health Care: Nuts and Bolts Maximal Tolerated Activity
of Radioactive Iodine for Metastatic Thyroid Cancer Teaching Old Radiopharmaceuticals New Tricks Intraoperative Detection Devices and Probes Molecular Imaging
of Lung Inflammation Standardization
of Advanced PET / SPECT Data Acquisition and Analysis Thyroid Cancer Management: Novel Therapeutics and Management Options Targeting Radionuclide
Therapy in Various Non-Malignant Arthritic Conditions Using Radiosynoviorthesis (RSO) Are You Prepared for a Radiation Accident?
After decades
of conflict between conventional physicians and
alternative doctors who recognized EDTA chelation
therapy as an effective treatment for coronary artery disease, the Trial to Assess Chelation Therapy (TACT) was completed i
therapy as an effective treatment for coronary artery disease, the
Trial to Assess Chelation
Therapy (TACT) was completed i
Therapy (TACT) was completed in 2012.